Global Biosimilars & Follow-on-Biologics Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Biosimilars & Follow-on-Biologics Industry Forecast” looks at past sales and reviews total world Biosimilars & Follow-on-Biologics sales in 2022, providing a comprehensive analysis by region and market sector of projected Biosimilars & Follow-on-Biologics sales for 2023 through 2029. With Biosimilars & Follow-on-Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biosimilars & Follow-on-Biologics industry.
This Insight Report provides a comprehensive analysis of the global Biosimilars & Follow-on-Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biosimilars & Follow-on-Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Biosimilars & Follow-on-Biologics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biosimilars & Follow-on-Biologics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biosimilars & Follow-on-Biologics.
The global Biosimilars & Follow-on-Biologics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Biosimilars & Follow-on-Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Biosimilars & Follow-on-Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Biosimilars & Follow-on-Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Biosimilars & Follow-on-Biologics players cover Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion, Biocon, Hospira, Merck Group and Biogen idec, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilars & Follow-on-Biologics market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Biosimilars & Follow-on-Biologics market?
What factors are driving Biosimilars & Follow-on-Biologics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biosimilars & Follow-on-Biologics market opportunities vary by end market size?
How does Biosimilars & Follow-on-Biologics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Biosimilars & Follow-on-Biologics Industry Forecast” looks at past sales and reviews total world Biosimilars & Follow-on-Biologics sales in 2022, providing a comprehensive analysis by region and market sector of projected Biosimilars & Follow-on-Biologics sales for 2023 through 2029. With Biosimilars & Follow-on-Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biosimilars & Follow-on-Biologics industry.
This Insight Report provides a comprehensive analysis of the global Biosimilars & Follow-on-Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biosimilars & Follow-on-Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Biosimilars & Follow-on-Biologics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biosimilars & Follow-on-Biologics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biosimilars & Follow-on-Biologics.
The global Biosimilars & Follow-on-Biologics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Biosimilars & Follow-on-Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Biosimilars & Follow-on-Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Biosimilars & Follow-on-Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Biosimilars & Follow-on-Biologics players cover Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion, Biocon, Hospira, Merck Group and Biogen idec, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilars & Follow-on-Biologics market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Human Growth Hormone
- Erythropoietin
- Monoclonal Antibodies
- Insulin
- Interferon
- Granulocyte-Colony Stimulating Factor
- Peptide
- Others
- Blood Disorders
- Oncology Diseases
- Chronic and Autoimmune Diseases
- Growth Hormone Deficiencies
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Synthon Pharmaceuticals
- Teva Pharmaceutical Industries
- LG Life Sciences
- Celltrion
- Biocon
- Hospira
- Merck Group
- Biogen idec, Inc.
- Genentech (Roche Group)
What is the 10-year outlook for the global Biosimilars & Follow-on-Biologics market?
What factors are driving Biosimilars & Follow-on-Biologics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biosimilars & Follow-on-Biologics market opportunities vary by end market size?
How does Biosimilars & Follow-on-Biologics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biosimilars & Follow-on-Biologics Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Biosimilars & Follow-on-Biologics by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Biosimilars & Follow-on-Biologics by Country/Region, 2018, 2022 & 2029
2.2 Biosimilars & Follow-on-Biologics Segment by Type
2.2.1 Human Growth Hormone
2.2.2 Erythropoietin
2.2.3 Monoclonal Antibodies
2.2.4 Insulin
2.2.5 Interferon
2.2.6 Granulocyte-Colony Stimulating Factor
2.2.7 Peptide
2.2.8 Others
2.3 Biosimilars & Follow-on-Biologics Sales by Type
2.3.1 Global Biosimilars & Follow-on-Biologics Sales Market Share by Type (2018-2023)
2.3.2 Global Biosimilars & Follow-on-Biologics Revenue and Market Share by Type (2018-2023)
2.3.3 Global Biosimilars & Follow-on-Biologics Sale Price by Type (2018-2023)
2.4 Biosimilars & Follow-on-Biologics Segment by Application
2.4.1 Blood Disorders
2.4.2 Oncology Diseases
2.4.3 Chronic and Autoimmune Diseases
2.4.4 Growth Hormone Deficiencies
2.4.5 Others
2.5 Biosimilars & Follow-on-Biologics Sales by Application
2.5.1 Global Biosimilars & Follow-on-Biologics Sale Market Share by Application (2018-2023)
2.5.2 Global Biosimilars & Follow-on-Biologics Revenue and Market Share by Application (2018-2023)
2.5.3 Global Biosimilars & Follow-on-Biologics Sale Price by Application (2018-2023)
3 GLOBAL BIOSIMILARS & FOLLOW-ON-BIOLOGICS BY COMPANY
3.1 Global Biosimilars & Follow-on-Biologics Breakdown Data by Company
3.1.1 Global Biosimilars & Follow-on-Biologics Annual Sales by Company (2018-2023)
3.1.2 Global Biosimilars & Follow-on-Biologics Sales Market Share by Company (2018-2023)
3.2 Global Biosimilars & Follow-on-Biologics Annual Revenue by Company (2018-2023)
3.2.1 Global Biosimilars & Follow-on-Biologics Revenue by Company (2018-2023)
3.2.2 Global Biosimilars & Follow-on-Biologics Revenue Market Share by Company (2018-2023)
3.3 Global Biosimilars & Follow-on-Biologics Sale Price by Company
3.4 Key Manufacturers Biosimilars & Follow-on-Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biosimilars & Follow-on-Biologics Product Location Distribution
3.4.2 Players Biosimilars & Follow-on-Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BIOSIMILARS & FOLLOW-ON-BIOLOGICS BY GEOGRAPHIC REGION
4.1 World Historic Biosimilars & Follow-on-Biologics Market Size by Geographic Region (2018-2023)
4.1.1 Global Biosimilars & Follow-on-Biologics Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Biosimilars & Follow-on-Biologics Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Biosimilars & Follow-on-Biologics Market Size by Country/Region (2018-2023)
4.2.1 Global Biosimilars & Follow-on-Biologics Annual Sales by Country/Region (2018-2023)
4.2.2 Global Biosimilars & Follow-on-Biologics Annual Revenue by Country/Region (2018-2023)
4.3 Americas Biosimilars & Follow-on-Biologics Sales Growth
4.4 APAC Biosimilars & Follow-on-Biologics Sales Growth
4.5 Europe Biosimilars & Follow-on-Biologics Sales Growth
4.6 Middle East & Africa Biosimilars & Follow-on-Biologics Sales Growth
5 AMERICAS
5.1 Americas Biosimilars & Follow-on-Biologics Sales by Country
5.1.1 Americas Biosimilars & Follow-on-Biologics Sales by Country (2018-2023)
5.1.2 Americas Biosimilars & Follow-on-Biologics Revenue by Country (2018-2023)
5.2 Americas Biosimilars & Follow-on-Biologics Sales by Type
5.3 Americas Biosimilars & Follow-on-Biologics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilars & Follow-on-Biologics Sales by Region
6.1.1 APAC Biosimilars & Follow-on-Biologics Sales by Region (2018-2023)
6.1.2 APAC Biosimilars & Follow-on-Biologics Revenue by Region (2018-2023)
6.2 APAC Biosimilars & Follow-on-Biologics Sales by Type
6.3 APAC Biosimilars & Follow-on-Biologics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biosimilars & Follow-on-Biologics by Country
7.1.1 Europe Biosimilars & Follow-on-Biologics Sales by Country (2018-2023)
7.1.2 Europe Biosimilars & Follow-on-Biologics Revenue by Country (2018-2023)
7.2 Europe Biosimilars & Follow-on-Biologics Sales by Type
7.3 Europe Biosimilars & Follow-on-Biologics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biosimilars & Follow-on-Biologics by Country
8.1.1 Middle East & Africa Biosimilars & Follow-on-Biologics Sales by Country (2018-2023)
8.1.2 Middle East & Africa Biosimilars & Follow-on-Biologics Revenue by Country (2018-2023)
8.2 Middle East & Africa Biosimilars & Follow-on-Biologics Sales by Type
8.3 Middle East & Africa Biosimilars & Follow-on-Biologics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biosimilars & Follow-on-Biologics
10.3 Manufacturing Process Analysis of Biosimilars & Follow-on-Biologics
10.4 Industry Chain Structure of Biosimilars & Follow-on-Biologics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biosimilars & Follow-on-Biologics Distributors
11.3 Biosimilars & Follow-on-Biologics Customer
12 WORLD FORECAST REVIEW FOR BIOSIMILARS & FOLLOW-ON-BIOLOGICS BY GEOGRAPHIC REGION
12.1 Global Biosimilars & Follow-on-Biologics Market Size Forecast by Region
12.1.1 Global Biosimilars & Follow-on-Biologics Forecast by Region (2024-2029)
12.1.2 Global Biosimilars & Follow-on-Biologics Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biosimilars & Follow-on-Biologics Forecast by Type
12.7 Global Biosimilars & Follow-on-Biologics Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
13.1.3 Novartis Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Synthon Pharmaceuticals
13.2.1 Synthon Pharmaceuticals Company Information
13.2.2 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
13.2.3 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Synthon Pharmaceuticals Main Business Overview
13.2.5 Synthon Pharmaceuticals Latest Developments
13.3 Teva Pharmaceutical Industries
13.3.1 Teva Pharmaceutical Industries Company Information
13.3.2 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
13.3.3 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Teva Pharmaceutical Industries Main Business Overview
13.3.5 Teva Pharmaceutical Industries Latest Developments
13.4 LG Life Sciences
13.4.1 LG Life Sciences Company Information
13.4.2 LG Life Sciences Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
13.4.3 LG Life Sciences Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 LG Life Sciences Main Business Overview
13.4.5 LG Life Sciences Latest Developments
13.5 Celltrion
13.5.1 Celltrion Company Information
13.5.2 Celltrion Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
13.5.3 Celltrion Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Celltrion Main Business Overview
13.5.5 Celltrion Latest Developments
13.6 Biocon
13.6.1 Biocon Company Information
13.6.2 Biocon Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
13.6.3 Biocon Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Biocon Main Business Overview
13.6.5 Biocon Latest Developments
13.7 Hospira
13.7.1 Hospira Company Information
13.7.2 Hospira Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
13.7.3 Hospira Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hospira Main Business Overview
13.7.5 Hospira Latest Developments
13.8 Merck Group
13.8.1 Merck Group Company Information
13.8.2 Merck Group Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
13.8.3 Merck Group Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Merck Group Main Business Overview
13.8.5 Merck Group Latest Developments
13.9 Biogen idec, Inc.
13.9.1 Biogen idec, Inc. Company Information
13.9.2 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
13.9.3 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Biogen idec, Inc. Main Business Overview
13.9.5 Biogen idec, Inc. Latest Developments
13.10 Genentech (Roche Group)
13.10.1 Genentech (Roche Group) Company Information
13.10.2 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
13.10.3 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Genentech (Roche Group) Main Business Overview
13.10.5 Genentech (Roche Group) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biosimilars & Follow-on-Biologics Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Biosimilars & Follow-on-Biologics by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Biosimilars & Follow-on-Biologics by Country/Region, 2018, 2022 & 2029
2.2 Biosimilars & Follow-on-Biologics Segment by Type
2.2.1 Human Growth Hormone
2.2.2 Erythropoietin
2.2.3 Monoclonal Antibodies
2.2.4 Insulin
2.2.5 Interferon
2.2.6 Granulocyte-Colony Stimulating Factor
2.2.7 Peptide
2.2.8 Others
2.3 Biosimilars & Follow-on-Biologics Sales by Type
2.3.1 Global Biosimilars & Follow-on-Biologics Sales Market Share by Type (2018-2023)
2.3.2 Global Biosimilars & Follow-on-Biologics Revenue and Market Share by Type (2018-2023)
2.3.3 Global Biosimilars & Follow-on-Biologics Sale Price by Type (2018-2023)
2.4 Biosimilars & Follow-on-Biologics Segment by Application
2.4.1 Blood Disorders
2.4.2 Oncology Diseases
2.4.3 Chronic and Autoimmune Diseases
2.4.4 Growth Hormone Deficiencies
2.4.5 Others
2.5 Biosimilars & Follow-on-Biologics Sales by Application
2.5.1 Global Biosimilars & Follow-on-Biologics Sale Market Share by Application (2018-2023)
2.5.2 Global Biosimilars & Follow-on-Biologics Revenue and Market Share by Application (2018-2023)
2.5.3 Global Biosimilars & Follow-on-Biologics Sale Price by Application (2018-2023)
3 GLOBAL BIOSIMILARS & FOLLOW-ON-BIOLOGICS BY COMPANY
3.1 Global Biosimilars & Follow-on-Biologics Breakdown Data by Company
3.1.1 Global Biosimilars & Follow-on-Biologics Annual Sales by Company (2018-2023)
3.1.2 Global Biosimilars & Follow-on-Biologics Sales Market Share by Company (2018-2023)
3.2 Global Biosimilars & Follow-on-Biologics Annual Revenue by Company (2018-2023)
3.2.1 Global Biosimilars & Follow-on-Biologics Revenue by Company (2018-2023)
3.2.2 Global Biosimilars & Follow-on-Biologics Revenue Market Share by Company (2018-2023)
3.3 Global Biosimilars & Follow-on-Biologics Sale Price by Company
3.4 Key Manufacturers Biosimilars & Follow-on-Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biosimilars & Follow-on-Biologics Product Location Distribution
3.4.2 Players Biosimilars & Follow-on-Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BIOSIMILARS & FOLLOW-ON-BIOLOGICS BY GEOGRAPHIC REGION
4.1 World Historic Biosimilars & Follow-on-Biologics Market Size by Geographic Region (2018-2023)
4.1.1 Global Biosimilars & Follow-on-Biologics Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Biosimilars & Follow-on-Biologics Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Biosimilars & Follow-on-Biologics Market Size by Country/Region (2018-2023)
4.2.1 Global Biosimilars & Follow-on-Biologics Annual Sales by Country/Region (2018-2023)
4.2.2 Global Biosimilars & Follow-on-Biologics Annual Revenue by Country/Region (2018-2023)
4.3 Americas Biosimilars & Follow-on-Biologics Sales Growth
4.4 APAC Biosimilars & Follow-on-Biologics Sales Growth
4.5 Europe Biosimilars & Follow-on-Biologics Sales Growth
4.6 Middle East & Africa Biosimilars & Follow-on-Biologics Sales Growth
5 AMERICAS
5.1 Americas Biosimilars & Follow-on-Biologics Sales by Country
5.1.1 Americas Biosimilars & Follow-on-Biologics Sales by Country (2018-2023)
5.1.2 Americas Biosimilars & Follow-on-Biologics Revenue by Country (2018-2023)
5.2 Americas Biosimilars & Follow-on-Biologics Sales by Type
5.3 Americas Biosimilars & Follow-on-Biologics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilars & Follow-on-Biologics Sales by Region
6.1.1 APAC Biosimilars & Follow-on-Biologics Sales by Region (2018-2023)
6.1.2 APAC Biosimilars & Follow-on-Biologics Revenue by Region (2018-2023)
6.2 APAC Biosimilars & Follow-on-Biologics Sales by Type
6.3 APAC Biosimilars & Follow-on-Biologics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biosimilars & Follow-on-Biologics by Country
7.1.1 Europe Biosimilars & Follow-on-Biologics Sales by Country (2018-2023)
7.1.2 Europe Biosimilars & Follow-on-Biologics Revenue by Country (2018-2023)
7.2 Europe Biosimilars & Follow-on-Biologics Sales by Type
7.3 Europe Biosimilars & Follow-on-Biologics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biosimilars & Follow-on-Biologics by Country
8.1.1 Middle East & Africa Biosimilars & Follow-on-Biologics Sales by Country (2018-2023)
8.1.2 Middle East & Africa Biosimilars & Follow-on-Biologics Revenue by Country (2018-2023)
8.2 Middle East & Africa Biosimilars & Follow-on-Biologics Sales by Type
8.3 Middle East & Africa Biosimilars & Follow-on-Biologics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biosimilars & Follow-on-Biologics
10.3 Manufacturing Process Analysis of Biosimilars & Follow-on-Biologics
10.4 Industry Chain Structure of Biosimilars & Follow-on-Biologics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biosimilars & Follow-on-Biologics Distributors
11.3 Biosimilars & Follow-on-Biologics Customer
12 WORLD FORECAST REVIEW FOR BIOSIMILARS & FOLLOW-ON-BIOLOGICS BY GEOGRAPHIC REGION
12.1 Global Biosimilars & Follow-on-Biologics Market Size Forecast by Region
12.1.1 Global Biosimilars & Follow-on-Biologics Forecast by Region (2024-2029)
12.1.2 Global Biosimilars & Follow-on-Biologics Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biosimilars & Follow-on-Biologics Forecast by Type
12.7 Global Biosimilars & Follow-on-Biologics Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
13.1.3 Novartis Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Synthon Pharmaceuticals
13.2.1 Synthon Pharmaceuticals Company Information
13.2.2 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
13.2.3 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Synthon Pharmaceuticals Main Business Overview
13.2.5 Synthon Pharmaceuticals Latest Developments
13.3 Teva Pharmaceutical Industries
13.3.1 Teva Pharmaceutical Industries Company Information
13.3.2 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
13.3.3 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Teva Pharmaceutical Industries Main Business Overview
13.3.5 Teva Pharmaceutical Industries Latest Developments
13.4 LG Life Sciences
13.4.1 LG Life Sciences Company Information
13.4.2 LG Life Sciences Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
13.4.3 LG Life Sciences Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 LG Life Sciences Main Business Overview
13.4.5 LG Life Sciences Latest Developments
13.5 Celltrion
13.5.1 Celltrion Company Information
13.5.2 Celltrion Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
13.5.3 Celltrion Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Celltrion Main Business Overview
13.5.5 Celltrion Latest Developments
13.6 Biocon
13.6.1 Biocon Company Information
13.6.2 Biocon Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
13.6.3 Biocon Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Biocon Main Business Overview
13.6.5 Biocon Latest Developments
13.7 Hospira
13.7.1 Hospira Company Information
13.7.2 Hospira Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
13.7.3 Hospira Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hospira Main Business Overview
13.7.5 Hospira Latest Developments
13.8 Merck Group
13.8.1 Merck Group Company Information
13.8.2 Merck Group Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
13.8.3 Merck Group Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Merck Group Main Business Overview
13.8.5 Merck Group Latest Developments
13.9 Biogen idec, Inc.
13.9.1 Biogen idec, Inc. Company Information
13.9.2 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
13.9.3 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Biogen idec, Inc. Main Business Overview
13.9.5 Biogen idec, Inc. Latest Developments
13.10 Genentech (Roche Group)
13.10.1 Genentech (Roche Group) Company Information
13.10.2 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
13.10.3 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Genentech (Roche Group) Main Business Overview
13.10.5 Genentech (Roche Group) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biosimilars & Follow-on-Biologics Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Biosimilars & Follow-on-Biologics Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Human Growth Hormone
Table 4. Major Players of Erythropoietin
Table 5. Major Players of Monoclonal Antibodies
Table 6. Major Players of Insulin
Table 7. Major Players of Interferon
Table 8. Major Players of Granulocyte-Colony Stimulating Factor
Table 9. Major Players of Peptide
Table 10. Major Players of Others
Table 11. Global Biosimilars & Follow-on-Biologics Sales by Type (2018-2023) & (K Pcs)
Table 12. Global Biosimilars & Follow-on-Biologics Sales Market Share by Type (2018-2023)
Table 13. Global Biosimilars & Follow-on-Biologics Revenue by Type (2018-2023) & ($ million)
Table 14. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Type (2018-2023)
Table 15. Global Biosimilars & Follow-on-Biologics Sale Price by Type (2018-2023) & (USD/Pcs)
Table 16. Global Biosimilars & Follow-on-Biologics Sales by Application (2018-2023) & (K Pcs)
Table 17. Global Biosimilars & Follow-on-Biologics Sales Market Share by Application (2018-2023)
Table 18. Global Biosimilars & Follow-on-Biologics Revenue by Application (2018-2023)
Table 19. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Application (2018-2023)
Table 20. Global Biosimilars & Follow-on-Biologics Sale Price by Application (2018-2023) & (USD/Pcs)
Table 21. Global Biosimilars & Follow-on-Biologics Sales by Company (2018-2023) & (K Pcs)
Table 22. Global Biosimilars & Follow-on-Biologics Sales Market Share by Company (2018-2023)
Table 23. Global Biosimilars & Follow-on-Biologics Revenue by Company (2018-2023) ($ Millions)
Table 24. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Company (2018-2023)
Table 25. Global Biosimilars & Follow-on-Biologics Sale Price by Company (2018-2023) & (USD/Pcs)
Table 26. Key Manufacturers Biosimilars & Follow-on-Biologics Producing Area Distribution and Sales Area
Table 27. Players Biosimilars & Follow-on-Biologics Products Offered
Table 28. Biosimilars & Follow-on-Biologics Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Biosimilars & Follow-on-Biologics Sales by Geographic Region (2018-2023) & (K Pcs)
Table 32. Global Biosimilars & Follow-on-Biologics Sales Market Share Geographic Region (2018-2023)
Table 33. Global Biosimilars & Follow-on-Biologics Revenue by Geographic Region (2018-2023) & ($ millions)
Table 34. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Geographic Region (2018-2023)
Table 35. Global Biosimilars & Follow-on-Biologics Sales by Country/Region (2018-2023) & (K Pcs)
Table 36. Global Biosimilars & Follow-on-Biologics Sales Market Share by Country/Region (2018-2023)
Table 37. Global Biosimilars & Follow-on-Biologics Revenue by Country/Region (2018-2023) & ($ millions)
Table 38. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Country/Region (2018-2023)
Table 39. Americas Biosimilars & Follow-on-Biologics Sales by Country (2018-2023) & (K Pcs)
Table 40. Americas Biosimilars & Follow-on-Biologics Sales Market Share by Country (2018-2023)
Table 41. Americas Biosimilars & Follow-on-Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 42. Americas Biosimilars & Follow-on-Biologics Revenue Market Share by Country (2018-2023)
Table 43. Americas Biosimilars & Follow-on-Biologics Sales by Type (2018-2023) & (K Pcs)
Table 44. Americas Biosimilars & Follow-on-Biologics Sales by Application (2018-2023) & (K Pcs)
Table 45. APAC Biosimilars & Follow-on-Biologics Sales by Region (2018-2023) & (K Pcs)
Table 46. APAC Biosimilars & Follow-on-Biologics Sales Market Share by Region (2018-2023)
Table 47. APAC Biosimilars & Follow-on-Biologics Revenue by Region (2018-2023) & ($ Millions)
Table 48. APAC Biosimilars & Follow-on-Biologics Revenue Market Share by Region (2018-2023)
Table 49. APAC Biosimilars & Follow-on-Biologics Sales by Type (2018-2023) & (K Pcs)
Table 50. APAC Biosimilars & Follow-on-Biologics Sales by Application (2018-2023) & (K Pcs)
Table 51. Europe Biosimilars & Follow-on-Biologics Sales by Country (2018-2023) & (K Pcs)
Table 52. Europe Biosimilars & Follow-on-Biologics Sales Market Share by Country (2018-2023)
Table 53. Europe Biosimilars & Follow-on-Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 54. Europe Biosimilars & Follow-on-Biologics Revenue Market Share by Country (2018-2023)
Table 55. Europe Biosimilars & Follow-on-Biologics Sales by Type (2018-2023) & (K Pcs)
Table 56. Europe Biosimilars & Follow-on-Biologics Sales by Application (2018-2023) & (K Pcs)
Table 57. Middle East & Africa Biosimilars & Follow-on-Biologics Sales by Country (2018-2023) & (K Pcs)
Table 58. Middle East & Africa Biosimilars & Follow-on-Biologics Sales Market Share by Country (2018-2023)
Table 59. Middle East & Africa Biosimilars & Follow-on-Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 60. Middle East & Africa Biosimilars & Follow-on-Biologics Revenue Market Share by Country (2018-2023)
Table 61. Middle East & Africa Biosimilars & Follow-on-Biologics Sales by Type (2018-2023) & (K Pcs)
Table 62. Middle East & Africa Biosimilars & Follow-on-Biologics Sales by Application (2018-2023) & (K Pcs)
Table 63. Key Market Drivers & Growth Opportunities of Biosimilars & Follow-on-Biologics
Table 64. Key Market Challenges & Risks of Biosimilars & Follow-on-Biologics
Table 65. Key Industry Trends of Biosimilars & Follow-on-Biologics
Table 66. Biosimilars & Follow-on-Biologics Raw Material
Table 67. Key Suppliers of Raw Materials
Table 68. Biosimilars & Follow-on-Biologics Distributors List
Table 69. Biosimilars & Follow-on-Biologics Customer List
Table 70. Global Biosimilars & Follow-on-Biologics Sales Forecast by Region (2024-2029) & (K Pcs)
Table 71. Global Biosimilars & Follow-on-Biologics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Americas Biosimilars & Follow-on-Biologics Sales Forecast by Country (2024-2029) & (K Pcs)
Table 73. Americas Biosimilars & Follow-on-Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. APAC Biosimilars & Follow-on-Biologics Sales Forecast by Region (2024-2029) & (K Pcs)
Table 75. APAC Biosimilars & Follow-on-Biologics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 76. Europe Biosimilars & Follow-on-Biologics Sales Forecast by Country (2024-2029) & (K Pcs)
Table 77. Europe Biosimilars & Follow-on-Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Middle East & Africa Biosimilars & Follow-on-Biologics Sales Forecast by Country (2024-2029) & (K Pcs)
Table 79. Middle East & Africa Biosimilars & Follow-on-Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 80. Global Biosimilars & Follow-on-Biologics Sales Forecast by Type (2024-2029) & (K Pcs)
Table 81. Global Biosimilars & Follow-on-Biologics Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 82. Global Biosimilars & Follow-on-Biologics Sales Forecast by Application (2024-2029) & (K Pcs)
Table 83. Global Biosimilars & Follow-on-Biologics Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 84. Novartis Basic Information, Biosimilars & Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 85. Novartis Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
Table 86. Novartis Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 87. Novartis Main Business
Table 88. Novartis Latest Developments
Table 89. Synthon Pharmaceuticals Basic Information, Biosimilars & Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 90. Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
Table 91. Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 92. Synthon Pharmaceuticals Main Business
Table 93. Synthon Pharmaceuticals Latest Developments
Table 94. Teva Pharmaceutical Industries Basic Information, Biosimilars & Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 95. Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
Table 96. Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 97. Teva Pharmaceutical Industries Main Business
Table 98. Teva Pharmaceutical Industries Latest Developments
Table 99. LG Life Sciences Basic Information, Biosimilars & Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 100. LG Life Sciences Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
Table 101. LG Life Sciences Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 102. LG Life Sciences Main Business
Table 103. LG Life Sciences Latest Developments
Table 104. Celltrion Basic Information, Biosimilars & Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 105. Celltrion Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
Table 106. Celltrion Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 107. Celltrion Main Business
Table 108. Celltrion Latest Developments
Table 109. Biocon Basic Information, Biosimilars & Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 110. Biocon Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
Table 111. Biocon Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 112. Biocon Main Business
Table 113. Biocon Latest Developments
Table 114. Hospira Basic Information, Biosimilars & Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 115. Hospira Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
Table 116. Hospira Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 117. Hospira Main Business
Table 118. Hospira Latest Developments
Table 119. Merck Group Basic Information, Biosimilars & Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 120. Merck Group Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
Table 121. Merck Group Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 122. Merck Group Main Business
Table 123. Merck Group Latest Developments
Table 124. Biogen idec, Inc. Basic Information, Biosimilars & Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 125. Biogen idec, Inc. Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
Table 126. Biogen idec, Inc. Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 127. Biogen idec, Inc. Main Business
Table 128. Biogen idec, Inc. Latest Developments
Table 129. Genentech (Roche Group) Basic Information, Biosimilars & Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 130. Genentech (Roche Group) Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
Table 131. Genentech (Roche Group) Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 132. Genentech (Roche Group) Main Business
Table 133. Genentech (Roche Group) Latest Developments
Table 1. Biosimilars & Follow-on-Biologics Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Biosimilars & Follow-on-Biologics Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Human Growth Hormone
Table 4. Major Players of Erythropoietin
Table 5. Major Players of Monoclonal Antibodies
Table 6. Major Players of Insulin
Table 7. Major Players of Interferon
Table 8. Major Players of Granulocyte-Colony Stimulating Factor
Table 9. Major Players of Peptide
Table 10. Major Players of Others
Table 11. Global Biosimilars & Follow-on-Biologics Sales by Type (2018-2023) & (K Pcs)
Table 12. Global Biosimilars & Follow-on-Biologics Sales Market Share by Type (2018-2023)
Table 13. Global Biosimilars & Follow-on-Biologics Revenue by Type (2018-2023) & ($ million)
Table 14. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Type (2018-2023)
Table 15. Global Biosimilars & Follow-on-Biologics Sale Price by Type (2018-2023) & (USD/Pcs)
Table 16. Global Biosimilars & Follow-on-Biologics Sales by Application (2018-2023) & (K Pcs)
Table 17. Global Biosimilars & Follow-on-Biologics Sales Market Share by Application (2018-2023)
Table 18. Global Biosimilars & Follow-on-Biologics Revenue by Application (2018-2023)
Table 19. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Application (2018-2023)
Table 20. Global Biosimilars & Follow-on-Biologics Sale Price by Application (2018-2023) & (USD/Pcs)
Table 21. Global Biosimilars & Follow-on-Biologics Sales by Company (2018-2023) & (K Pcs)
Table 22. Global Biosimilars & Follow-on-Biologics Sales Market Share by Company (2018-2023)
Table 23. Global Biosimilars & Follow-on-Biologics Revenue by Company (2018-2023) ($ Millions)
Table 24. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Company (2018-2023)
Table 25. Global Biosimilars & Follow-on-Biologics Sale Price by Company (2018-2023) & (USD/Pcs)
Table 26. Key Manufacturers Biosimilars & Follow-on-Biologics Producing Area Distribution and Sales Area
Table 27. Players Biosimilars & Follow-on-Biologics Products Offered
Table 28. Biosimilars & Follow-on-Biologics Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Biosimilars & Follow-on-Biologics Sales by Geographic Region (2018-2023) & (K Pcs)
Table 32. Global Biosimilars & Follow-on-Biologics Sales Market Share Geographic Region (2018-2023)
Table 33. Global Biosimilars & Follow-on-Biologics Revenue by Geographic Region (2018-2023) & ($ millions)
Table 34. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Geographic Region (2018-2023)
Table 35. Global Biosimilars & Follow-on-Biologics Sales by Country/Region (2018-2023) & (K Pcs)
Table 36. Global Biosimilars & Follow-on-Biologics Sales Market Share by Country/Region (2018-2023)
Table 37. Global Biosimilars & Follow-on-Biologics Revenue by Country/Region (2018-2023) & ($ millions)
Table 38. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Country/Region (2018-2023)
Table 39. Americas Biosimilars & Follow-on-Biologics Sales by Country (2018-2023) & (K Pcs)
Table 40. Americas Biosimilars & Follow-on-Biologics Sales Market Share by Country (2018-2023)
Table 41. Americas Biosimilars & Follow-on-Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 42. Americas Biosimilars & Follow-on-Biologics Revenue Market Share by Country (2018-2023)
Table 43. Americas Biosimilars & Follow-on-Biologics Sales by Type (2018-2023) & (K Pcs)
Table 44. Americas Biosimilars & Follow-on-Biologics Sales by Application (2018-2023) & (K Pcs)
Table 45. APAC Biosimilars & Follow-on-Biologics Sales by Region (2018-2023) & (K Pcs)
Table 46. APAC Biosimilars & Follow-on-Biologics Sales Market Share by Region (2018-2023)
Table 47. APAC Biosimilars & Follow-on-Biologics Revenue by Region (2018-2023) & ($ Millions)
Table 48. APAC Biosimilars & Follow-on-Biologics Revenue Market Share by Region (2018-2023)
Table 49. APAC Biosimilars & Follow-on-Biologics Sales by Type (2018-2023) & (K Pcs)
Table 50. APAC Biosimilars & Follow-on-Biologics Sales by Application (2018-2023) & (K Pcs)
Table 51. Europe Biosimilars & Follow-on-Biologics Sales by Country (2018-2023) & (K Pcs)
Table 52. Europe Biosimilars & Follow-on-Biologics Sales Market Share by Country (2018-2023)
Table 53. Europe Biosimilars & Follow-on-Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 54. Europe Biosimilars & Follow-on-Biologics Revenue Market Share by Country (2018-2023)
Table 55. Europe Biosimilars & Follow-on-Biologics Sales by Type (2018-2023) & (K Pcs)
Table 56. Europe Biosimilars & Follow-on-Biologics Sales by Application (2018-2023) & (K Pcs)
Table 57. Middle East & Africa Biosimilars & Follow-on-Biologics Sales by Country (2018-2023) & (K Pcs)
Table 58. Middle East & Africa Biosimilars & Follow-on-Biologics Sales Market Share by Country (2018-2023)
Table 59. Middle East & Africa Biosimilars & Follow-on-Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 60. Middle East & Africa Biosimilars & Follow-on-Biologics Revenue Market Share by Country (2018-2023)
Table 61. Middle East & Africa Biosimilars & Follow-on-Biologics Sales by Type (2018-2023) & (K Pcs)
Table 62. Middle East & Africa Biosimilars & Follow-on-Biologics Sales by Application (2018-2023) & (K Pcs)
Table 63. Key Market Drivers & Growth Opportunities of Biosimilars & Follow-on-Biologics
Table 64. Key Market Challenges & Risks of Biosimilars & Follow-on-Biologics
Table 65. Key Industry Trends of Biosimilars & Follow-on-Biologics
Table 66. Biosimilars & Follow-on-Biologics Raw Material
Table 67. Key Suppliers of Raw Materials
Table 68. Biosimilars & Follow-on-Biologics Distributors List
Table 69. Biosimilars & Follow-on-Biologics Customer List
Table 70. Global Biosimilars & Follow-on-Biologics Sales Forecast by Region (2024-2029) & (K Pcs)
Table 71. Global Biosimilars & Follow-on-Biologics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Americas Biosimilars & Follow-on-Biologics Sales Forecast by Country (2024-2029) & (K Pcs)
Table 73. Americas Biosimilars & Follow-on-Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. APAC Biosimilars & Follow-on-Biologics Sales Forecast by Region (2024-2029) & (K Pcs)
Table 75. APAC Biosimilars & Follow-on-Biologics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 76. Europe Biosimilars & Follow-on-Biologics Sales Forecast by Country (2024-2029) & (K Pcs)
Table 77. Europe Biosimilars & Follow-on-Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Middle East & Africa Biosimilars & Follow-on-Biologics Sales Forecast by Country (2024-2029) & (K Pcs)
Table 79. Middle East & Africa Biosimilars & Follow-on-Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 80. Global Biosimilars & Follow-on-Biologics Sales Forecast by Type (2024-2029) & (K Pcs)
Table 81. Global Biosimilars & Follow-on-Biologics Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 82. Global Biosimilars & Follow-on-Biologics Sales Forecast by Application (2024-2029) & (K Pcs)
Table 83. Global Biosimilars & Follow-on-Biologics Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 84. Novartis Basic Information, Biosimilars & Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 85. Novartis Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
Table 86. Novartis Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 87. Novartis Main Business
Table 88. Novartis Latest Developments
Table 89. Synthon Pharmaceuticals Basic Information, Biosimilars & Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 90. Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
Table 91. Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 92. Synthon Pharmaceuticals Main Business
Table 93. Synthon Pharmaceuticals Latest Developments
Table 94. Teva Pharmaceutical Industries Basic Information, Biosimilars & Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 95. Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
Table 96. Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 97. Teva Pharmaceutical Industries Main Business
Table 98. Teva Pharmaceutical Industries Latest Developments
Table 99. LG Life Sciences Basic Information, Biosimilars & Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 100. LG Life Sciences Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
Table 101. LG Life Sciences Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 102. LG Life Sciences Main Business
Table 103. LG Life Sciences Latest Developments
Table 104. Celltrion Basic Information, Biosimilars & Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 105. Celltrion Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
Table 106. Celltrion Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 107. Celltrion Main Business
Table 108. Celltrion Latest Developments
Table 109. Biocon Basic Information, Biosimilars & Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 110. Biocon Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
Table 111. Biocon Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 112. Biocon Main Business
Table 113. Biocon Latest Developments
Table 114. Hospira Basic Information, Biosimilars & Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 115. Hospira Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
Table 116. Hospira Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 117. Hospira Main Business
Table 118. Hospira Latest Developments
Table 119. Merck Group Basic Information, Biosimilars & Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 120. Merck Group Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
Table 121. Merck Group Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 122. Merck Group Main Business
Table 123. Merck Group Latest Developments
Table 124. Biogen idec, Inc. Basic Information, Biosimilars & Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 125. Biogen idec, Inc. Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
Table 126. Biogen idec, Inc. Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 127. Biogen idec, Inc. Main Business
Table 128. Biogen idec, Inc. Latest Developments
Table 129. Genentech (Roche Group) Basic Information, Biosimilars & Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 130. Genentech (Roche Group) Biosimilars & Follow-on-Biologics Product Portfolios and Specifications
Table 131. Genentech (Roche Group) Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 132. Genentech (Roche Group) Main Business
Table 133. Genentech (Roche Group) Latest Developments
LIST OF FIGURES
Figure 1. Picture of Biosimilars & Follow-on-Biologics
Figure 2. Biosimilars & Follow-on-Biologics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biosimilars & Follow-on-Biologics Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Biosimilars & Follow-on-Biologics Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Biosimilars & Follow-on-Biologics Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Human Growth Hormone
Figure 10. Product Picture of Erythropoietin
Figure 11. Product Picture of Monoclonal Antibodies
Figure 12. Product Picture of Insulin
Figure 13. Product Picture of Interferon
Figure 14. Product Picture of Granulocyte-Colony Stimulating Factor
Figure 15. Product Picture of Peptide
Figure 16. Product Picture of Others
Figure 17. Global Biosimilars & Follow-on-Biologics Sales Market Share by Type in 2022
Figure 18. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Type (2018-2023)
Figure 19. Biosimilars & Follow-on-Biologics Consumed in Blood Disorders
Figure 20. Global Biosimilars & Follow-on-Biologics Market: Blood Disorders (2018-2023) & (K Pcs)
Figure 21. Biosimilars & Follow-on-Biologics Consumed in Oncology Diseases
Figure 22. Global Biosimilars & Follow-on-Biologics Market: Oncology Diseases (2018-2023) & (K Pcs)
Figure 23. Biosimilars & Follow-on-Biologics Consumed in Chronic and Autoimmune Diseases
Figure 24. Global Biosimilars & Follow-on-Biologics Market: Chronic and Autoimmune Diseases (2018-2023) & (K Pcs)
Figure 25. Biosimilars & Follow-on-Biologics Consumed in Growth Hormone Deficiencies
Figure 26. Global Biosimilars & Follow-on-Biologics Market: Growth Hormone Deficiencies (2018-2023) & (K Pcs)
Figure 27. Biosimilars & Follow-on-Biologics Consumed in Others
Figure 28. Global Biosimilars & Follow-on-Biologics Market: Others (2018-2023) & (K Pcs)
Figure 29. Global Biosimilars & Follow-on-Biologics Sales Market Share by Application (2022)
Figure 30. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Application in 2022
Figure 31. Biosimilars & Follow-on-Biologics Sales Market by Company in 2022 (K Pcs)
Figure 32. Global Biosimilars & Follow-on-Biologics Sales Market Share by Company in 2022
Figure 33. Biosimilars & Follow-on-Biologics Revenue Market by Company in 2022 ($ Million)
Figure 34. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Company in 2022
Figure 35. Global Biosimilars & Follow-on-Biologics Sales Market Share by Geographic Region (2018-2023)
Figure 36. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Geographic Region in 2022
Figure 37. Americas Biosimilars & Follow-on-Biologics Sales 2018-2023 (K Pcs)
Figure 38. Americas Biosimilars & Follow-on-Biologics Revenue 2018-2023 ($ Millions)
Figure 39. APAC Biosimilars & Follow-on-Biologics Sales 2018-2023 (K Pcs)
Figure 40. APAC Biosimilars & Follow-on-Biologics Revenue 2018-2023 ($ Millions)
Figure 41. Europe Biosimilars & Follow-on-Biologics Sales 2018-2023 (K Pcs)
Figure 42. Europe Biosimilars & Follow-on-Biologics Revenue 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Biosimilars & Follow-on-Biologics Sales 2018-2023 (K Pcs)
Figure 44. Middle East & Africa Biosimilars & Follow-on-Biologics Revenue 2018-2023 ($ Millions)
Figure 45. Americas Biosimilars & Follow-on-Biologics Sales Market Share by Country in 2022
Figure 46. Americas Biosimilars & Follow-on-Biologics Revenue Market Share by Country in 2022
Figure 47. Americas Biosimilars & Follow-on-Biologics Sales Market Share by Type (2018-2023)
Figure 48. Americas Biosimilars & Follow-on-Biologics Sales Market Share by Application (2018-2023)
Figure 49. United States Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 50. Canada Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 51. Mexico Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 52. Brazil Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 53. APAC Biosimilars & Follow-on-Biologics Sales Market Share by Region in 2022
Figure 54. APAC Biosimilars & Follow-on-Biologics Revenue Market Share by Regions in 2022
Figure 55. APAC Biosimilars & Follow-on-Biologics Sales Market Share by Type (2018-2023)
Figure 56. APAC Biosimilars & Follow-on-Biologics Sales Market Share by Application (2018-2023)
Figure 57. China Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 58. Japan Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 59. South Korea Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 60. Southeast Asia Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 61. India Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 62. Australia Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 63. China Taiwan Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 64. Europe Biosimilars & Follow-on-Biologics Sales Market Share by Country in 2022
Figure 65. Europe Biosimilars & Follow-on-Biologics Revenue Market Share by Country in 2022
Figure 66. Europe Biosimilars & Follow-on-Biologics Sales Market Share by Type (2018-2023)
Figure 67. Europe Biosimilars & Follow-on-Biologics Sales Market Share by Application (2018-2023)
Figure 68. Germany Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 69. France Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 70. UK Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 71. Italy Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 72. Russia Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 73. Middle East & Africa Biosimilars & Follow-on-Biologics Sales Market Share by Country in 2022
Figure 74. Middle East & Africa Biosimilars & Follow-on-Biologics Revenue Market Share by Country in 2022
Figure 75. Middle East & Africa Biosimilars & Follow-on-Biologics Sales Market Share by Type (2018-2023)
Figure 76. Middle East & Africa Biosimilars & Follow-on-Biologics Sales Market Share by Application (2018-2023)
Figure 77. Egypt Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 78. South Africa Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 79. Israel Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 80. Turkey Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 81. GCC Country Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 82. Manufacturing Cost Structure Analysis of Biosimilars & Follow-on-Biologics in 2022
Figure 83. Manufacturing Process Analysis of Biosimilars & Follow-on-Biologics
Figure 84. Industry Chain Structure of Biosimilars & Follow-on-Biologics
Figure 85. Channels of Distribution
Figure 86. Global Biosimilars & Follow-on-Biologics Sales Market Forecast by Region (2024-2029)
Figure 87. Global Biosimilars & Follow-on-Biologics Revenue Market Share Forecast by Region (2024-2029)
Figure 88. Global Biosimilars & Follow-on-Biologics Sales Market Share Forecast by Type (2024-2029)
Figure 89. Global Biosimilars & Follow-on-Biologics Revenue Market Share Forecast by Type (2024-2029)
Figure 90. Global Biosimilars & Follow-on-Biologics Sales Market Share Forecast by Application (2024-2029)
Figure 91. Global Biosimilars & Follow-on-Biologics Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Biosimilars & Follow-on-Biologics
Figure 2. Biosimilars & Follow-on-Biologics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biosimilars & Follow-on-Biologics Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Biosimilars & Follow-on-Biologics Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Biosimilars & Follow-on-Biologics Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Human Growth Hormone
Figure 10. Product Picture of Erythropoietin
Figure 11. Product Picture of Monoclonal Antibodies
Figure 12. Product Picture of Insulin
Figure 13. Product Picture of Interferon
Figure 14. Product Picture of Granulocyte-Colony Stimulating Factor
Figure 15. Product Picture of Peptide
Figure 16. Product Picture of Others
Figure 17. Global Biosimilars & Follow-on-Biologics Sales Market Share by Type in 2022
Figure 18. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Type (2018-2023)
Figure 19. Biosimilars & Follow-on-Biologics Consumed in Blood Disorders
Figure 20. Global Biosimilars & Follow-on-Biologics Market: Blood Disorders (2018-2023) & (K Pcs)
Figure 21. Biosimilars & Follow-on-Biologics Consumed in Oncology Diseases
Figure 22. Global Biosimilars & Follow-on-Biologics Market: Oncology Diseases (2018-2023) & (K Pcs)
Figure 23. Biosimilars & Follow-on-Biologics Consumed in Chronic and Autoimmune Diseases
Figure 24. Global Biosimilars & Follow-on-Biologics Market: Chronic and Autoimmune Diseases (2018-2023) & (K Pcs)
Figure 25. Biosimilars & Follow-on-Biologics Consumed in Growth Hormone Deficiencies
Figure 26. Global Biosimilars & Follow-on-Biologics Market: Growth Hormone Deficiencies (2018-2023) & (K Pcs)
Figure 27. Biosimilars & Follow-on-Biologics Consumed in Others
Figure 28. Global Biosimilars & Follow-on-Biologics Market: Others (2018-2023) & (K Pcs)
Figure 29. Global Biosimilars & Follow-on-Biologics Sales Market Share by Application (2022)
Figure 30. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Application in 2022
Figure 31. Biosimilars & Follow-on-Biologics Sales Market by Company in 2022 (K Pcs)
Figure 32. Global Biosimilars & Follow-on-Biologics Sales Market Share by Company in 2022
Figure 33. Biosimilars & Follow-on-Biologics Revenue Market by Company in 2022 ($ Million)
Figure 34. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Company in 2022
Figure 35. Global Biosimilars & Follow-on-Biologics Sales Market Share by Geographic Region (2018-2023)
Figure 36. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Geographic Region in 2022
Figure 37. Americas Biosimilars & Follow-on-Biologics Sales 2018-2023 (K Pcs)
Figure 38. Americas Biosimilars & Follow-on-Biologics Revenue 2018-2023 ($ Millions)
Figure 39. APAC Biosimilars & Follow-on-Biologics Sales 2018-2023 (K Pcs)
Figure 40. APAC Biosimilars & Follow-on-Biologics Revenue 2018-2023 ($ Millions)
Figure 41. Europe Biosimilars & Follow-on-Biologics Sales 2018-2023 (K Pcs)
Figure 42. Europe Biosimilars & Follow-on-Biologics Revenue 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Biosimilars & Follow-on-Biologics Sales 2018-2023 (K Pcs)
Figure 44. Middle East & Africa Biosimilars & Follow-on-Biologics Revenue 2018-2023 ($ Millions)
Figure 45. Americas Biosimilars & Follow-on-Biologics Sales Market Share by Country in 2022
Figure 46. Americas Biosimilars & Follow-on-Biologics Revenue Market Share by Country in 2022
Figure 47. Americas Biosimilars & Follow-on-Biologics Sales Market Share by Type (2018-2023)
Figure 48. Americas Biosimilars & Follow-on-Biologics Sales Market Share by Application (2018-2023)
Figure 49. United States Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 50. Canada Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 51. Mexico Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 52. Brazil Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 53. APAC Biosimilars & Follow-on-Biologics Sales Market Share by Region in 2022
Figure 54. APAC Biosimilars & Follow-on-Biologics Revenue Market Share by Regions in 2022
Figure 55. APAC Biosimilars & Follow-on-Biologics Sales Market Share by Type (2018-2023)
Figure 56. APAC Biosimilars & Follow-on-Biologics Sales Market Share by Application (2018-2023)
Figure 57. China Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 58. Japan Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 59. South Korea Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 60. Southeast Asia Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 61. India Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 62. Australia Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 63. China Taiwan Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 64. Europe Biosimilars & Follow-on-Biologics Sales Market Share by Country in 2022
Figure 65. Europe Biosimilars & Follow-on-Biologics Revenue Market Share by Country in 2022
Figure 66. Europe Biosimilars & Follow-on-Biologics Sales Market Share by Type (2018-2023)
Figure 67. Europe Biosimilars & Follow-on-Biologics Sales Market Share by Application (2018-2023)
Figure 68. Germany Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 69. France Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 70. UK Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 71. Italy Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 72. Russia Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 73. Middle East & Africa Biosimilars & Follow-on-Biologics Sales Market Share by Country in 2022
Figure 74. Middle East & Africa Biosimilars & Follow-on-Biologics Revenue Market Share by Country in 2022
Figure 75. Middle East & Africa Biosimilars & Follow-on-Biologics Sales Market Share by Type (2018-2023)
Figure 76. Middle East & Africa Biosimilars & Follow-on-Biologics Sales Market Share by Application (2018-2023)
Figure 77. Egypt Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 78. South Africa Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 79. Israel Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 80. Turkey Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 81. GCC Country Biosimilars & Follow-on-Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 82. Manufacturing Cost Structure Analysis of Biosimilars & Follow-on-Biologics in 2022
Figure 83. Manufacturing Process Analysis of Biosimilars & Follow-on-Biologics
Figure 84. Industry Chain Structure of Biosimilars & Follow-on-Biologics
Figure 85. Channels of Distribution
Figure 86. Global Biosimilars & Follow-on-Biologics Sales Market Forecast by Region (2024-2029)
Figure 87. Global Biosimilars & Follow-on-Biologics Revenue Market Share Forecast by Region (2024-2029)
Figure 88. Global Biosimilars & Follow-on-Biologics Sales Market Share Forecast by Type (2024-2029)
Figure 89. Global Biosimilars & Follow-on-Biologics Revenue Market Share Forecast by Type (2024-2029)
Figure 90. Global Biosimilars & Follow-on-Biologics Sales Market Share Forecast by Application (2024-2029)
Figure 91. Global Biosimilars & Follow-on-Biologics Revenue Market Share Forecast by Application (2024-2029)
